A High Level Overview of Louisiana's Cannabis Market
Publisher |
Josh Kincaid
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Nov 16, 2021
Episode Duration |
00:04:52

Louisiana has one of the most restrictive frameworks in the nation, but poised for much stronger growth in January when its nine dispensaries will begin selling cannabis flower instead of only tinctures, topicals and portable vaporizers.

Edibles and “metered-dose” vaporizers and delivery became available in 2020, and those products immediately were popular, despite regulatory red tape that hindered both products getting to market.

With the addition of flower and some other tweaks to the MMJ program, medical cannabis sales in Louisiana are projected to roughly double next year to around $110 million next year, and could get as high as $400 million by 2025 according to MJBizFactbook.

Despite the changes, the market remains among the most restrictive in the United States and licensed businesses still report obstacles to success.

Show Notes: Louisiana medical marijuana market poised for strong sales after lackluster performance https://mjbizdaily.com/louisiana-medical-marijuana-market-poised-for-strong-sales-after-lackluster-performance/

Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/

Episode 811 The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com

Music Info: Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018Artist: LuxrayBeats

Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data

Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers. This is only entertainment.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review